|
|
||||||||
J Biol Chem, Vol. 275, Issue 5, 3438-3445, February 4, 2000
From the The AML-1-encoded transcription factor, AML-1B,
regulates numerous hematopoietic-specific genes. Inappropriate
expression of AML-1-family proteins is oncogenic in cell culture
systems and in mice. To understand the oncogenic functions of AML-1, we established cell lines expressing AML-1B to examine the role of AML-1
in the cell cycle. DNA content analysis and bromodeoxyuridine pulse-chase studies indicated that entry into the S phase of the cell
cycle was accelerated by up to 4 h in AML-1B-expressing 32D.3 myeloid progenitor cells as compared with control cells or cells expressing E2F-1. However, AML-1B was not able to induce continued cell
cycle progression in the absence of growth factors. The DNA binding and
transactivation domains of AML-1B were required for altering the cell
cycle. Thus, AML-1B is the first transcription factor that affects the
timing of the mammalian cell cycle.
Expression of the AML-1 Oncogene Shortens the G1
Phase of the Cell Cycle*
§¶,
§
,
§,
§,
§**,
,
§§, and
§¶¶
Departments of Biochemistry and Medicine and
the § Vanderbilt-Ingram Cancer Center, Vanderbilt University
School of Medicine, Nashville, Tennessee 37232 and

Department of Pathology and the
§§ Department of Tumor Cell Biology, St. Jude
Children's Research Hospital, Memphis, Tennessee 38105
*
This work was supported by National Institutes of Health
(NCI) Grants RO1 AG13726, RO1-CA64140, RO1-CA77274 (to S. W. H.), and
F32 CA77167 (to J. J. W.), by NCI Center Grant CA68485, and by the
Vanderbilt-Ingram Cancer Center.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
A Special Fellow of the Leukemia Society of America
(3827-99).
**
A Fellow of the Leukemia Society of America (5669-99).
¶¶
To whom correspondence should be addressed: Dept. Of
Biochemistry, Vanderbilt Cancer Center, Vanderbilt University School of
Medicine, Medical Research Building II, Rm. 512, 23rd and Pierce, Nashville, TN 37232. Tel.: 615-936-3582; Fax: 615-936-1790; E-mail: scott.hiebert@mcmail.vanderbilt.edu.
This article has been cited by other articles:
![]() |
R. Bakshi, S. K. Zaidi, S. Pande, M. Q. Hassan, D. W. Young, M. Montecino, J. B. Lian, A. J. van Wijnen, J. L. Stein, and G. S. Stein The leukemogenic t(8;21) fusion protein AML1-ETO controls rRNA genes and associates with nucleolar-organizing regions at mitotic chromosomes J. Cell Sci., December 1, 2008; 121(23): 3981 - 3990. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Chyla, I. Moreno-Miralles, M. A. Steapleton, M. A. Thompson, S. Bhaskara, M. Engel, and S. W. Hiebert Deletion of Mtg16, a Target of t(16;21), Alters Hematopoietic Progenitor Cell Proliferation and Lineage Allocation Mol. Cell. Biol., October 15, 2008; 28(20): 6234 - 6247. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Dayyani, J. Wang, J.-R. J. Yeh, E.-Y. Ahn, E. Tobey, D.-E. Zhang, I. D. Bernstein, R. T. Peterson, and D. A. Sweetser Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival Blood, April 15, 2008; 111(8): 4338 - 4347. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. McCabe, D. D. Spyropoulos, D. Martin, and C. S. Moreno Genome-Wide Analysis of the Homeobox C6 Transcriptional Network in Prostate Cancer Cancer Res., March 15, 2008; 68(6): 1988 - 1996. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, F. B. Fried, H. Guo, and A. D. Friedman Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation Blood, February 1, 2008; 111(3): 1193 - 1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Horsfield, S. H. Anagnostou, J. K.-H. Hu, K. H. Y. Cho, R. Geisler, G. Lieschke, K. E. Crosier, and P. S. Crosier Cohesin-dependent regulation of Runx genes Development, July 15, 2007; 134(14): 2639 - 2649. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Biggs, L. F. Peterson, Y. Zhang, A. S. Kraft, and D.-E. Zhang AML1/RUNX1 Phosphorylation by Cyclin-Dependent Kinases Regulates the Degradation of AML1/RUNX1 by the Anaphase-Promoting Complex Mol. Cell. Biol., October 15, 2006; 26(20): 7420 - 7429. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Blyth, F. Vaillant, L. Hanlon, N. Mackay, M. Bell, A. Jenkins, J. C. Neil, and E. R. Cameron Runx2 and MYC Collaborate in Lymphoma Development by Suppressing Apoptotic and Growth Arrest Pathways In vivo Cancer Res., February 15, 2006; 66(4): 2195 - 2201. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Peterson, A. Boyapati, V. Ranganathan, A. Iwama, D. G. Tenen, S. Tsai, and D.-E. Zhang The Hematopoietic Transcription Factor AML1 (RUNX1) Is Negatively Regulated by the Cell Cycle Protein Cyclin D3 Mol. Cell. Biol., December 1, 2005; 25(23): 10205 - 10219. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nimmo, A. Antebi, and A. Woollard mab-2 encodes RNT-1, a C. elegans Runx homologue essential for controlling cell proliferation in a stem cell-like developmental lineage Development, November 15, 2005; 132(22): 5043 - 5054. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A.G. Stams, M. L. den Boer, H. B. Beverloo, J. P.P. Meijerink, E. R. van Wering, G. E. Janka-Schaub, and R. Pieters Expression Levels of TEL, AML1, and the Fusion Products TEL-AML1 and AML1-TEL versus Drug Sensitivity and Clinical Outcome in t(12;21)-Positive Pediatric Acute Lymphoblastic Leukemia Clin. Cancer Res., April 15, 2005; 11(8): 2974 - 2980. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Theriault, H. N. Nuthall, Z. Dong, R. Lo, F. Barnabe-Heider, F. D. Miller, and S. Stifani Role for Runx1 in the Proliferation and Neuronal Differentiation of Selected Progenitor Cells in the Mammalian Nervous System J. Neurosci., February 23, 2005; 25(8): 2050 - 2061. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bernardin-Fried, T. Kummalue, S. Leijen, M. I. Collector, K. Ravid, and A. D. Friedman AML1/RUNX1 Increases During G1 to S Cell Cycle Progression Independent of Cytokine-dependent Phosphorylation and Induces Cyclin D3 Gene Expression J. Biol. Chem., April 9, 2004; 279(15): 15678 - 15687. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pratap, M. Galindo, S. K. Zaidi, D. Vradii, B. M. Bhat, J. A. Robinson, J.-Y. Choi, T. Komori, J. L. Stein, J. B. Lian, et al. Cell Growth Regulatory Role of Runx2 during Proliferative Expansion of Preosteoblasts Cancer Res., September 1, 2003; 63(17): 5357 - 5362. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Kalejta and T. Shenk The Human Cytomegalovirus UL82 Gene Product (pp71) Accelerates Progression through the G1 Phase of the Cell Cycle J. Virol., March 15, 2003; 77(6): 3451 - 3459. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Baker Small Unstable Apoptotic Protein, an Apoptosis-associated Protein, Suppresses Proliferation of Myeloid Cells Cancer Res., February 1, 2003; 63(3): 705 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kummalue, J. Lou, and A. D. Friedman Multimerization via Its Myosin Domain Facilitates Nuclear Localization and Inhibition of Core Binding Factor (CBF) Activities by the CBF{beta}-Smooth Muscle Myosin Heavy Chain Myeloid Leukemia Oncoprotein Mol. Cell. Biol., December 1, 2002; 22(23): 8278 - 8291. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yang, W. Wang, R. Cleaves, M. Zahurak, L. Cheng, C. I. Civin, and A. D. Friedman Acceleration of G1 Cooperates with Core Binding Factor {beta}-Smooth Muscle Myosin Heavy Chain to Induce Acute Leukemia in Mice Cancer Res., April 1, 2002; 62(8): 2232 - 2235. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Mulloy, J. Cammenga, K. L. MacKenzie, F. J. Berguido, M. A. S. Moore, and S. D. Nimer The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells Blood, January 1, 2002; 99(1): 15 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Amann, J. Nip, D. K. Strom, B. Lutterbach, H. Harada, N. Lenny, J. R. Downing, S. Meyers, and S. W. Hiebert ETO, a Target of t(8;21) in Acute Leukemia, Makes Distinct Contacts with Multiple Histone Deacetylases and Binds mSin3A through Its Oligomerization Domain Mol. Cell. Biol., October 1, 2001; 21(19): 6470 - 6483. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Burel, N. Harakawa, L. Zhou, T. Pabst, D. G. Tenen, and D.-E. Zhang Dichotomy of AML1-ETO Functions: Growth Arrest versus Block of Differentiation Mol. Cell. Biol., August 15, 2001; 21(16): 5577 - 5590. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |